-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us This project forms part of a broader programme of research in proof-theoretic semantics based at UCL and in the Institute of Philosophy at the University of London’s School of Advanced
-
LCA methods to propose strategies to reduce waste and evaluate the potential for industrial ecologies. The post holder will be one of a team of UCL-based researchers working as part of VaxHub
-
work on the genomics of epilepsy within a wider programme of translational research, including genomics and climate change, under the supervision of Professor Sanjay Sisodiya. You will oversee a team of
-
how best to translate these findings into changes in practice and policy. The post is based within the Population Policy and Practice Programme (PPP) at the UCL Great Ormond Street Institute of Child
-
• Employee assistance programme: Staff Support Service • Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. Our commitment to Equ ality, Diversity and